Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1Classical hematology 1

Conditions

Melanoma 3Colitis, Ulcerative 3Inflammatory Bowel Diseases 2Crohn Disease 2Pancreatic Neoplasms 1Lymphoma 1Lung Neoplasms 1Hepatitis 1Graft vs Host Disease 1Colitis 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Cachexia 1Bronchiolitis Obliterans Syndrome 1Arthritis, Rheumatoid 1Anorexia 1Anemia 1

Interventions

Megestrol Acetate 2ostarine 1clazakizumab 1anamorelin 1alkaloid GB18 1Sodium Chloride 1Infliximab 1Gemcitabine 1Food 1Dietary Supplements 1Caseins 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Cachexia × Infliximab × Clear all
NCT00060502 2011-05-17

A Study of the Safety and Effectiveness of Infliximab (Remicade) in Patients With Pancreatic Cancer Related Cachexia

Centocor, Inc.

Phase 2 Completed
73 enrolled
Classical hematologyGastrointestinal

Anemia, Anorexia, Cachexia, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡